Why Hypertension Research Is So Important

Many with Hypertension often have no symptoms, but it’s still doing damage to the body. Left untreated or uncontrolled, it can damage blood vessels and cause a Stroke or Heart Attack.

What many don’t realize, too, is that poor vascular (blood vessel) health in middle-age is a risk factor for dementia later in life. This is because it lessens the amount of oxygen that flows to the brain due to damaged heart valves.

Though approved blood pressure drugs exist, many struggle to take their daily meds, so it may not work well. Still others need more than one medication—or are untreated and need to start on one! For these reasons, volunteers are needed for research studies assessing investigational medications for HBP—some of which may require very infrequent dosing.

Take the next step to see if you qualify for local research studies for people with Hypertension, also known as High Blood Pressure. But don’t delay — space is limited!

Get started now

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exam rooms throughly between every patient visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.